BALTIMORE – Mobile health company emocha, which uses video-based technology to improve medication adherence, is building on a flurry of recent activity to push into additional markets.
The startup, which currently serves the public health market in areas like Washington, New England and Texas, was recently named among Fast Company’s 2018 Most Innovative Companies, ranking No. 9 out of 10 in the health category. It also named Tom Carroll as COO, charging him with leading the company’s market expansion.
“We’re going to push into broader markets like payers and hospitals—even life insurance,” said Carroll, who has more than 25 years of experience in health care finance, including at investment banking firms Stifel Nicolaus and RuxtonPark Healthcare Capital. “We’re really looking across the board regarding constituents.”
Patients use emocha’s mobile app to video-record themselves taking their medication. The videos are uploaded to a platform for care providers to validate and collect dose-by-dose adherence data. Communication tools are also built into the platform so providers can send messages of encouragement to patients or check in if a dose was missed.
Carroll said emocha is about to launch its new platform, which includes an update to the back-end and can address more pervasive diseases, in addition to hepatitis C, tuberculosis and opioid use disorder.
“It’s the grown-up version of what we’ve been working with and can reach a broader group,” he said.
The Fast Company ranking recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness. The company was cited for its use of technology to improve medication adherence for the treatment of high priority health challenges.
“Our technology allows people to leverage something low-tech like a smartphone and prove that through directly observed therapy, people tend to do what they’re supposed to be doing in terms of health care,” Carroll said.